Organized by the department of Intensive Care Emergency Medicine of Erasme Hospital, Free University of Brussels, in association with the Belgian Society of Intensive Care and Emergency Medicine (SIZ), this meeting has become established as one of the largest in its field, now attracting more than 5,360 participants from around the world. The objectives of this symposium are to provide participants with an up to date review of the most recent, clinically relevant developments in research, therapy, and management of the critically ill. The meeting is open to all Physicians, Nurses and other health professionals with an interest in critical care or emergency medicine.

BioPorto will be promoting The NGAL Test™ for in-vitro diagnostic use in the European Union and selected countries. (For further information please visit Patent information)

What is NGAL?
NGAL is a novel biomarker for diagnosing acute kidney injury (AKI). NGAL provides a new way to identify patients at risk of developing potentially severe acute kidney injury (AKI). To learn more about ngal please visit:

Product Managers, Elaine Lundberg ( and Jakob Ohm Eriksen ( will welcome you at our booth nr. 1.13.

For further information on the ISICEM congress - please go to: